ERVW-1 and dengue disease: Results indicate that these DNA vaccines drove correct expression of such proteins in mammalian cells, since they were recognized by a polyclonal anti-dengue ascitic fluid that contains antibodies reacting to epitopes present on the DENV2 envelope protein during virus infection in different cells [27], [40], [41].